Evolent Health (EVH) Revenue (2015 - 2026)

Evolent Health has reported Revenue for 12 years, with the latest figure at $496.2 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 2.6% year-over-year to $496.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (down 21.26% YoY), and the FY2025 full-year result was $1.9 billion, down 26.56% from the prior year.
• Revenue for Q1 2026 stood at $496.2 million, up from $468.7 million in the prior quarter.
• The five-year high for Revenue was $647.1 million in Q2 2024, with the low at $297.1 million in Q1 2022.
• Average Revenue over 5 years is $484.9 million, with a median of $479.5 million recorded in 2025.
• Year-over-year, Revenue jumped 58.49% in 2022 and plunged 31.34% in 2025.
• Tracing EVH's Revenue over 5 years: stood at $382.4 million in 2022, then surged by 45.4% to $556.1 million in 2023, then grew by 16.27% to $646.5 million in 2024, then dropped by 27.5% to $468.7 million in 2025, then rose by 5.87% to $496.2 million in 2026.
• The last three Revenue figures came in at $496.2 million (Q1 2026), $468.7 million (Q4 2025), and $479.5 million (Q3 2025), per Business Quant data.

Peer Comparison